Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00178-4/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_infocus-oncology_wclc24&_hsenc=p2ANqtz--G4hmGSxdEdolzBx4TwZDuO3VQomkpQh0I6BX0BYXs2kK3jk-1M3qkTA6PVJ3DPpredCqNCxOnCbQHaYFJwEZAT6m_bg&_hsmi=324755362&utm_content=323463400&utm_source=hs_email